Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 11;11(1):34.
doi: 10.3390/toxins11010034.

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?

Bernard Poulain  1 , Michel R Popoff  2
Affiliations
Review

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?

Bernard Poulain et al. Toxins (Basel). .

Abstract

Botulinum neurotoxins (BoNTs) are the most lethal toxins among all bacterial, animal, plant and chemical poisonous compounds. Although a great effort has been made to understand their mode of action, some questions are still open. Why, and for what benefit, have environmental bacteria that accidentally interact with their host engineered so diverse and so specific toxins targeting one of the most specialized physiological processes, the neuroexocytosis of higher organisms? The extreme potency of BoNT does not result from only one hyperactive step, but in contrast to other potent lethal toxins, from multi-step activity. The cumulative effects of the different steps, each having a limited effect, make BoNTs the most potent lethal toxins. This is a unique mode of evolution of a toxic compound, the high potency of which results from multiple steps driven by unknown selection pressure, targeting one of the most critical physiological process of higher organisms.

Keywords: Clostridium botulinum; SNARE proteins; botulinum neurotoxins; botulism; neuroexocytosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic summary of the BoNT activity steps.
See this image and copyright information in PMC

References

    1. Johnson E.A. Clostridial toxins as therapeuic agents: Benefits and nature’s most toxic proteins. Annu. Rev. Microbiol. 1999;53:551–575. doi: 10.1146/annurev.micro.53.1.551. - DOI - PubMed
    1. Schantz E.J., Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 1992;56:80–99. - PMC - PubMed
    1. Peck M.W. Clostridium botulinum and the safety of minimally heated, chilled foods: An emerging issue? J. Appl. Microbiol. 2006;101:556–570. doi: 10.1111/j.1365-2672.2006.02987.x. - DOI - PubMed
    1. Barash J.R., Arnon S.S. A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. J. Infect. Dis. 2014;209:183–191. doi: 10.1093/infdis/jit449. - DOI - PubMed
    1. Maslanka S.E., Luquez C., Dykes J.K., Tepp W.H., Pier C.L., Pellett S., Raphael B.H., Kalb S.R., Barr J.R., Rao A., et al. A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure with Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized with Serotype A Antitoxin. J. Infect. Dis. 2016;213:379–385. doi: 10.1093/infdis/jiv327. - DOI - PMC - PubMed

LinkOut - more resources